Format

Send to

Choose Destination
Int J Mol Sci. 2019 Jun 10;20(11). pii: E2819. doi: 10.3390/ijms20112819.

Chiari Malformation Type 1 in EPAS1-Associated Syndrome.

Author information

1
Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. jared.rosenblum@nih.gov.
2
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. dominic.maggio@nih.gov.
3
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. Ying.pang@nih.gov.
4
Department of Internal Medicine and Pediatrics, Georgetown University Medical Center, Washington, DC 20007, USA. matt.a.nazari@gmail.com.
5
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. melissa.gonzales@nih.gov.
6
Division of Endocrinology, Diabetes & Metabolism, Tufts Medical Center, Boston, MA 02111, USA. rlechan@tuftsmedicalcenter.org.
7
Radiology, George Washington University, Washington, DC 20052, USA. medpixman@gmail.com.
8
MedPix® National Library of Medicine, 8600 Rockville Pike Bethesda, MD 20894, USA. medpixman@gmail.com.
9
Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. zhengping.zhuang@nih.gov.
10
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. zhengping.zhuang@nih.gov.
11
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. karel@mail.nih.gov.
12
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. heissj@ninds.nih.gov.

Abstract

A syndrome of multiple paragangliomas/pheochromocytomas, somatostatinoma, and polycythemia due to somatic mosaic gain-of-function mutation of EPAS1, encoding HIF-2α, was previously described. HIF-2α has been implicated in endochondral and intramembranous ossification. Abnormal bone growth of the skull base may lead to Chiari malformation type I. We report two cases of EPAS1 gain-of-function mutation syndrome with Chiari malformation and developmental skull base anomalies. Patients were referred to the Section on Medical Endocrinology, Eunice Kennedy Shriver NICHD, NIH for evaluation of recurrent and metastatic paragangliomas or pheochromocytoma. The syndrome was confirmed genetically by identification of the functional EPAS1 gain-of-function mutation in the resected tumors and circulating leukocytes. Both patients were confirmed for characteristics of EPAS1 gain-of-function mutation syndrome by complete blood count (CBC), plasma biochemistry, and computed tomography (CT) of the abdomen and pelvis. Chiari malformation type I and abnormal bony development of the posterior fossa was found on MRI and CT of the head. The present study implicates EPAS1 mutations in abnormal posterior fossa development resulting in Chiari malformation type I.

KEYWORDS:

Chiari malformation type I; EPAS1; HIF-2α; Pacak-Zhuang syndrome

PMID:
31185588
PMCID:
PMC6600383
DOI:
10.3390/ijms20112819
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center